Karuna Therapeutics (KRTX) Buy, Sell or Hold

Karuna Therapeutics (KRTX)

329.83

-0.00 (0.00%)

as of Mar 15, 2024, 12:00:00 am Market Open.

4 watching

BUY

They have been working on a drug for schizophrenia. Early this month they released phase 3 trail results--which were great. Shares jumped 72% and keep climbing.

Wealthica Track your Stocks in your Watch List

COMMENT

An early-stage biopharma, so you can't buy their drugs right now, but they are developing drugs. Their lead drug treats schizophrenia as well as psychosis. Shares are up 21% YTD, but has pulled back hard in the past month.

Showing 1 to 2 of 2 entries

Karuna Therapeutics (KRTX) Frequently Asked Questions

What is Karuna Therapeutics stock symbol?

Karuna Therapeutics is a American stock, trading under the symbol KRTX (previously KRTX-Q on Stockchase) on the NASDAQ (KRTX). It is usually referred to as NASDAQ:KRTX or KRTX

Is Karuna Therapeutics a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on KRTX (previously KRTX-Q on Stockchase) on Stockchase. Read the latest expert commentary for Karuna Therapeutics.

Is Karuna Therapeutics a good investment or a top pick?

Karuna Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Karuna Therapeutics.

Why is Karuna Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Karuna Therapeutics.

Is Karuna Therapeutics worth watching?

Karuna Therapeutics is covered by Stockchase experts and is worth watching.

What is Karuna Therapeutics stock price?

On 2024-03-15, Karuna Therapeutics (KRTX) stock closed at a price of $329.83.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Karuna Therapeutics (KRTX)